Related Experiment Video
Updated: Nov 30, 2025
Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective
Published on: January 12, 2024
Guidelines for the diagnosis and treatment of osteoarthritis in China (2019 edition)
Zhiyi Zhang1, Cibo Huang2, Quan Jiang3
1Department of Rheumatology and Immunology, the First Affiliated Hospital of Harbin Medical University, Harbin, China.
Insights
This study presents China
Area of Science:
- Rheumatology
- Clinical Practice Guidelines
Background:
- Osteoarthritis (OA) poses a significant disease burden globally, particularly affecting middle-aged and elderly populations.
- Developing evidence-based guidelines is crucial for effective OA management in China.
Purpose of the Study:
- To establish an evidence-based diagnosis and treatment guideline for Osteoarthritis (OA) in China.
- To incorporate the latest scientific evidence into clinical practice.
Main Methods:
- Guideline development supported by the Rheumatology and Immunology Expert Committee.
- Utilized the GRADE approach for evidence quality and recommendation strength assessment.
- Adhered to the RIGHT checklist for transparent reporting.
Main Results:
- The guideline offers recommendations for OA diagnosis, risk monitoring, and evaluation.
- Provides guidance on treatment objectives, encompassing physical, medical, and surgical interventions.
Conclusions:
- This guideline serves as a decision-making tool for Chinese clinicians managing OA.
- Aims to improve the diagnosis and treatment of Osteoarthritis in China through evidence-based practices.
Abstract:
Osteoarthritis (OA) is a degenerative disease of middle-aged and elderly people, contributed a higher burden of disease in China and the world. In 2017, under the support of the Rheumatology and Immunology Expert Committee of the Cross-Strait Medical and Health Exchange Association. The objective was to develop an evidence-based diagnosis and treatment guideline for OA in China based on emerging new evidence. The guideline was registered at International Practice Guidelines Registry Platform (IPGRP-2018CN028). The grading of recommendations assessment, development and evaluation (GRADE) approach was used to rate the quality of evidence and the strength of recommendations, and the RIGHT (Reporting Items for Practice Guidelines in Healthcare) checklist was followed to report the guideline. The guideline provides recommendations for the OA diagnosis, disease risks monitoring and evaluate, treatment purpose and physical, medical and surgical interventions. This guideline is intended to serve as a tool for Chinese clinicians for the best decisions-making on diagnosis and treatment of OA.
